Avidity
Janghoon Lee has work experience as a Research Associate in Avidity Biosciences, Inc. starting from April 2023. Prior to that, they worked as a Research Associate in OliX Pharmaceuticals, Inc. from June 2022 to April 2023.
Janghoon Lee attended El Camino College from 2017 to 2019 where they studied Chemistry. Afterward, they pursued a Bachelor of Science degree in Molecular Synthesis at UC San Diego from 2019 to 2022.
Avidity
2 followers
Avidity Biosciences is pioneering a new class of precision medicines – antibody-siRNA conjugates (ASC™) – to deliver nucleic acid therapeutics against genetic drivers of disease. Our ASCs have drug-like properties similar to antibodies and antibody-drug conjugates. Importantly, their unique siRNA-based “payloads” permit selective targeting of disease-associated mRNAs against virtually any target of interest.